Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Deals channel feed
Two healthcare SPACs go public, with several more on the hunt for deals
10 months ago
Financing
Ten biotech executives who reaped the biggest M&A windfalls, netting $40M+ exit packages
10 months ago
People
Ipsen takes on another ADC, this time from a China-based biotech
10 months ago
R&D
Thermo Fisher closes $3.1B Olink acquisition after UK antitrust review is cleared
10 months ago
Diagnostics
Are 'next-gen' biotech acquirers experiencing their moment?
10 months ago
Startups
Pharma
Digital health deals rallied in the first half of 2024, though funding still trails last year
10 months ago
Financing
Health Tech
Lilly discloses its first biotech acquisition of the year, buying Morphic for $3.2B
10 months ago
Pharma
GSK reworks CureVac deal, paying $429M upfront to grab control of mRNA flu and Covid vaccines
10 months ago
Emergent, HHS disclose $250M updated contract that includes anthrax and smallpox vaccines
10 months ago
Pharma
Samsung Bio pulls in $1.06B manufacturing deal with unnamed US pharma company
10 months ago
Manufacturing
Seeking 'financial flexibility,' Esperion sells European royalty on cholesterol-lowering drugs
10 months ago
Financing
Pharma
UniQure sells Massachusetts manufacturing site to Genezen as it continues to downsize
10 months ago
Manufacturing
Lilly inks radiopharma deal with Radionetics, with rights to buy the biotech
10 months ago
Pharma
Eisai takes over development of ADC after Bristol Myers ends $650M collaboration
10 months ago
R&D
Rovi teases acquisition offers for its CDMO unit potentially worth €2B to €3B
10 months ago
Pharma
Manufacturing
What Coherus' $40M sale of its Humira biosimilar says about the crowded market
10 months ago
Pharma
Biogen is pursuing more dealmaking this year, with plans to spend up to $8B
10 months ago
R&D
AbbVie buys Third Rock's Celsius for $250M to expand IBD pipeline
10 months ago
Pharma
Maze spins its ALS antisense program into a secretive new company
10 months ago
Startups
Haleon to sell nicotine replacement therapy business to Dr. Reddy’s for $630M
10 months ago
Pharma
Amylyx, searching for post-ALS future, licenses a GLP-1 drug
10 months ago
R&D
Obesity care startup knownwell buys an AI weight loss platform
10 months ago
AI
Health Tech
Tectonic enters public markets in one of few biotech reverse mergers this year
10 months ago
Startups
Samsung Bio and Baxter dial up manufacturing deal to $223M
10 months ago
Manufacturing
First page
Previous page
12
13
14
15
16
17
18
Next page
Last page